Arie Belldegrun - 31 Dec 2025 SCHEDULE 13G/A Report for Allogene Therapeutics, Inc. Common Stock (ALLO)

Filing Manager
Arie Belldegrun
Reporting Manager
Arie Belldegrun, M.D.
Security
Allogene Therapeutics, Inc. Common Stock
Symbol
ALLO
Shares outstanding
228,416,724 shares
Disclosed Ownership
13,248,170 shares
Ownership
5.8%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 17:34:06 UTC
Date of event
31 Dec 2025
Previous filing
13 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Arie Belldegrun disclosed 5.8% ownership in Allogene Therapeutics, Inc. Common Stock (ALLO) on 31 Dec 2025."

Quick Takeaways

  • Arie Belldegrun filed SCHEDULE 13G/A for Allogene Therapeutics, Inc. Common Stock (ALLO).
  • Disclosed ownership: 5.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 13 Nov 2025.
  • Current filing was accepted on 17 Feb 2026, 17:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Arie Belldegrun, M.D. 5.8% 13,248,170 4,475,883 8,772,287 /s/ Arie Belldegrun Arie Belldegrun, M.D.
Bellco Legacy LLC 0.2% 539,867 0 539,867 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Bellco Legacy IV LLC 2.1% 4,710,120 0 4,710,120 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Vida Ventures LLC 0.8% 1,798,163 0 1,798,163 /s/ Arie Belldegrun By VV Manager LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director
Vida Ventures III, L.P. 0.8% 1,720,172 0 1,720,172 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director
Vida Ventures III-A, L.P. 0% 3,965 0 3,965 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,

Sponsored